The first-of-its-kind study published last week in the the 'American Journal of Clinical Nutrition' was conducted by Italian researchers among over 1,000 participants.
Danish pharmaceutical giant Novo Nordisk has said it is set to apply for regulatory approval of its once-a-week insulin drug, Icodec. Results of Phase-3 clinical trial shown 'promising results'.
Developed by US firm Merck & Co, Sitagliptin is used to treat Type 2 diabetes, a condition in which blood sugar goes up because the body does not produce or use insulin normally.
The ICMR has called a virtual meeting of pharma companies and NGOs to discuss the high pricing of cancer, diabetic, thyroid drugs, among others, on 17 August.
By turning a blind eye to the snakes in his own backyard, Trudeau is setting the stage for a disaster of epic proportions for his country, his people, and the world at large.
In Episode 1544 of CutTheClutter, Editor-in-Chief Shekhar Gupta looks at some top economists pointing to the pitfalls of ‘currency nationalism’ with data from 1991 to 2004.
While there are patrolling points (PP) 10, 11, 12, 12A and 13 in the Depsang Plains, the patrol in the region Monday was carried out to only one point as decided by India and China.
While we talk much about our military, we don’t put our national wallet where our mouth is. Nobody is saying we should double our defence spending, but current declining trend must be reversed.
COMMENTS